Related Experiment Video
Updated: May 26, 2026
08:23
Real-time Breath Analysis by Using Secondary Nanoelectrospray Ionization Coupled to High Resolution Mass Spectrometry
Published on: March 9, 2018
A breath test for malignant mesothelioma using an electronic nose
Eleanor A Chapman1, Paul S Thomas, Emily Stone
1Inflammation and Infection Research Centre, School of Medical Sciences, University of New South Wales, Sydney, Australia.
The European Respiratory Journal
|December 21, 2011
Summary
Detecting malignant mesothelioma (MM) early can improve survival. A carbon polymer array (CPA) electronic nose accurately identified MM patients from controls and those with asbestos-related diseases (ARDs) using breath volatile organic compounds (VOCs).
Area of Science:
- Pulmonary Medicine
- Biomarker Discovery
- Diagnostic Technology
Background:
- Malignant mesothelioma (MM) is a rare cancer with challenging early diagnosis, impacting survival rates.
- Early detection of MM is crucial for improving patient outcomes.
- Volatile organic compounds (VOCs) in exhaled breath offer potential as non-invasive disease biomarkers.
Purpose of the Study:
- To evaluate the efficacy of a carbon polymer array (CPA) electronic nose in distinguishing patients with MM from those with benign asbestos-related diseases (ARDs) and healthy controls.
- To assess the sensitivity and specificity of breath VOC profiling for MM detection.
- To explore the potential of CPA electronic nose technology as a screening tool for high-risk populations.
Main Methods:
- A cross-sectional, case-control study involving 20 MM patients, 18 ARD patients, and 42 control subjects.
- Exhaled breath samples were analyzed using the Cyranose 320 CPA electronic nose.
- Data analysis employed canonical discriminant analysis and principal component reduction for smell print interpretation.
Main Results:
- A CPA electronic nose distinguished new MM patients from control subjects with 95% accuracy.
- The system correctly identified patients with MM, ARDs, and controls in 88% of cases.
- Breath VOC profiling demonstrated high sensitivity and specificity in differentiating these groups.
Conclusions:
- Exhaled breath VOC profiling using a CPA electronic nose is a viable method for accurately distinguishing between malignant mesothelioma, asbestos-related diseases, and healthy individuals.
- This technology holds promise as a potential non-invasive screening tool for populations at risk of MM.
- Further development could lead to earlier MM diagnosis and improved survival rates.
